Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2023 | 1 |
2024 | 2 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
A comprehensive approach to evaluate genetic abnormalities in multiple myeloma using optical genome mapping.
Blood Cancer J. 2024 May 3;14(1):78. doi: 10.1038/s41408-024-01059-x.
Blood Cancer J. 2024.
PMID: 38702349
Free PMC article.
No abstract available.
Novel Anti-B-cell Maturation Antigen Alpha-Amanitin Antibody-drug Conjugate HDP-101 Shows Superior Activity to Belantamab Mafodotin and Enhanced Efficacy in Deletion 17p Myeloma Models.
Singh RK, Jones RJ, Shirazi F, Qin L, Zou J, Hong S, Wang H, Lee HC, Patel KK, Wan J, Choudhary RK, Kuiatse I, Pahl A, Orlowski RZ.
Singh RK, et al.
Res Sq [Preprint]. 2024 Jan 11:rs.3.rs-3843028. doi: 10.21203/rs.3.rs-3843028/v1.
Res Sq. 2024.
PMID: 38260385
Free PMC article.
Preprint.
Item in Clipboard
Antibody-Drug Conjugates for Multiple Myeloma: Just the Beginning, or the Beginning of the End?
Ray U, Orlowski RZ.
Ray U, et al.
Pharmaceuticals (Basel). 2023 Apr 14;16(4):590. doi: 10.3390/ph16040590.
Pharmaceuticals (Basel). 2023.
PMID: 37111346
Free PMC article.
Review.
Item in Clipboard
Cite
Cite